Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Respiratory Devices Market

Therapeutic Respiratory Devices Market Trends

Report ID: GMI696
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Therapeutic Respiratory Devices Market Trends

The increasing R&D spending on different technical breakthroughs in therapeutic respiratory devices will accelerate the market development. Advanced respiratory devices allow patients to utilize practical and user-friendly gadgets for the treatment of various respiratory disorders. Furthermore, the demand for portable and miniaturized therapeutic ventilators is picking pace as they are quick, affordable, and may be used outdoors without the supervision of doctors.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market size for therapeutic respiratory devices was USD 47.2 billion in 2022 and is projected to record 4.7% CAGR by 2032 attributed to the high prevalence of respiratory diseases worldwide.

The inhalers product segment is expected to amass more than USD 40 billion by 2032 attributed to the increasing availability of newly developed automated inhalers.

North America therapeutic respiratory devices is set to exhibit growth at over 3.5% CAGR from 2023 to 2032 owing to the high frequency of respiratory disorders and the growing availability of modern healthcare infrastructure.

Some of the key therapeutic respiratory device providers include Hill-Rom Services Inc. (Baxter), ResMed Inc., Drägerwerk AG & Co. KGaA, Hamilton Medical, Koninklijke Philips N.V., VYAIRE MEDICAL, INC., Invacare Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Breas Medical AB